Comradis is a full-service healthcare communications agency working exclusively on projects related to rare diseases and uncommon cancers. With capacity to support clients at every stage of treatment development, Comradis has specialist experience in a broad range of communication, commercialization and community-focused activities. Our goal is to ensure that novel therapies reach those that need them as quickly and cost-efficiently as possible.
We work with pharmaceutical companies, rare disease specialists and patient advocacy organizations from our offices in New Zealand, China, Singapore, UAE, Switzerland, the UK and USA.
Comradis is part of AMICULUM, an independent global healthcare communications and learning business established in 2001.